Meeting Announcements and Reviews

Announcements of Upcoming Meetings

 

metabolic disease therapies

 


cedars logo



DIABETES AND OBESITY SYMPOSIUM


Presented by Sports Spectacular Diabetes and Obesity Research Institute at Cedars-Sinai


October 5-6, 2017 Thalians Auditorium, 8730 Alden Drive, Plaza Level


This no-cost two-day symposium brings together top experts to present the latest findings and innovations in diabetes and obesity research. Sessions include: Prediabetes, Genetics, Insulin Action, Humans: “The Real Deal,” Brain and Glucose Metabolism. See agenda below.
Speakers:

  • Caroline Apovian, MD – Boston University
  • George Bray, MD – Pennington Institute
  • Sonia Caprio, MD – Yale University
  • Senta Georgia, PhD – Children’s Hospital of Los Angeles
  • Mark Goodarzi, MD, PhD – Cedars-Sinai
  • Kevin Hall, PhD – National Institutes of Health
  • Zach Knight, PhD – University of California at San Francisco
  • Valeriya Lyssenko, MD, PhD – University of Bergen, Norway
  • Katie Page, MD – University of Southern California
  • Leigh Perreault, MD – University of Colorado
  • Karen Reue, PhD – University of California at Los Angeles
  • Celine Riera, PhD – Cedars-Sinai
  • Alan Saltiel, PhD – University of California at San Diego
  • Marilyn Ader, PhD – Cedars-Sinai
  • Richard Bergman, PhD – Cedars-Sinai

All titles for poster presentations should be submitted by September 29th. All individuals interested in cutting edge research in Diabetes and Obesity are encouraged to attend. 
Please register to Hannah.Freed@cshs.org. Lunch and social programs provided for registered attendees only.

 

“How an old asthma drug could be a new diabetes treatment,” UC San Diego Health, features Dr. Alan R. Saltiel, August 15, 2017.

7th ANNUAL GNF – JDRF DIABETES RESEARCH SYMPOSIUM

New Frontier in Beta Cell Biology: Molecular Targeting to the Beta Cell

Thursday, April 27, 2017
8:30 a.m. – 4:00 p.m.
GNF
10675 John Jay Hopkins Dr.
San Diego, California 92121

Featured Speakers:
Reza Abdi, Harvard Medical School
Benjamin Cravatt, The Scripps Research Institute
Neal Devaraj, University of California, San Diego
Carmella Evans-Molina, Indiana University
Bryan Laffitte, Genomics Institute of the Novartis Research Foundation
Philip Low, Purdue University
Francesca Mulas, University of California, San Diego
Chun Zeng, University of California, San Diego
Liangfang Zhang, University of California, San Diego

Register before April 20, 2017 by visiting www.regonline.com/GNFJDRF

 

Summaries for Previous Meetings

 

 

 


May 17-18, 2016
8:00 am – 8:00 pm
LIPID MAPS Annual Meeting 2016: Lipidomics Impact on Metabolic, Cancer, Cardiovascular and Inflammatory Diseases
UNIVERSITY OF CALIFORNIA, SAN DIEGO
Scripps Seaside Forum
Host: Edward A. Dennis, Ph.D.
Contact: Odalis Felix dennisoffice@ucsd.edu
For more info: http://www.lipidmaps.org/meetings/2016annual/index.html

 

 

ANNUAL DRC RETREAt and Workshop, April 12, 2016

 

 

 

The 9th San Diego Beta Cell Society Meeting was held on Wednesday, November 4, 2015 at the UCSD Faculty Club. Keynote speaker, Dr. Marc Prentki from the Montreal Diabetes Research Center, presenedt on metabolic signaling in the pancreatic beta cell. The event will started at 4:00PM and featured talks from local young investigators.

Organized by Daniel Porte Jr., MD and Maike Sander, MD

 

LIPID MAPS Annual Meeting 2015

Lipidomics Impact on Cancer, Metabolic and Inflammatory Diseases

Meeting Dates
Tuesday, May 12, 2015
Wednesday, May 13, 2015
Early Registration Ends:
April 3, 2015
Poster Abstract Deadline
April 3, 2015
Location - La Jolla, CA
Scripps Seaside Forum, UCSD

Meeting Overview 
This is an exciting time for the emerging field of lipidomics. With the development and evolution of sophisticated mass spectrometers linked to highly efficient liquid chromatography systems, individual molecular species of lipids can now be isolated identified, and quantified, allowing us to begin to understand lipid metabolism and the treatment of lipid-based diseases (atherosclerosis, arthritis, cancer, diabetes, Alzheimer's disease, and other inflammatory diseases). Recent awareness that each category of lipid consists of thousands if not tens of thousands of individual molecular species requires sophisticated informatics to ensure consistent databasing and annotation of the numerous lipid molecular species and analysis of tremendous quantities of experimental data.
The goal of this meeting is to bring together biological and biomedical scientists in a wide range of fields to share new findings and methods in the broader lipidomics field and to explore joint efforts to extend the use of these powerful new methods to new applications. Presentations will provide an excellent introduction for scientists new to these methods, and are sure to be of interest to lipidomics veterans who want to learn the latest techniques and research results.

Program
This year's meeting program featured lipidomics impact on cancer, metabolic and inflammatory diseases.

Confirmed Speakers
• Alan Aderem (Seattle Biomedical Research Institute)
• Hiroyuki Arai (University of Tokyo, Japan)
• Nicolas G. Bazan (Louisiana State University)
• Steven Bensinger (University of California, Los Angeles)
• Ian A. Blair (University of Pennsylvania)
• George M. Carman (Rutgers University)
• Jason G. Cyster (University of California, San Francisco)
• Shelah Ferguson-Miller (Michigan State University)
• Tony Futerman (Weizmann Institute, Israel)
• Christian Metallo (University of California, San Diego)
• Marcia E. Newcomer (Louisiana State University)
• Daniel K. Nomura (University of California, Berkeley)
• Valerie O’Donnell (Cardiff University, UK)
• Hugh Rosen (The Scripps Research Institute)
• Marion B. Sewer (University of California, San Diego)
• Michael Snyder (Stanford University)
• Robert M. Stroud (University of California, San Francisco)
• Jean Vance (University of Alberta, Canada)
• David Wishart (University of Alberta, Canada)
• Huiyong Yin (Shanghai Institutes for Biological Sciences, China)

Poster Sessions will take place on both days of the meeting. Several lightning talks will be selected from poster submissions. 

The Networking Reception and Dinner Tuesday evening (included in the registration fee) are an opportunity for stimulating discussion and networking.

Questions?
Please contact Catherine Liu (dennisoffice@ucsd.edu, 858-534-2173) or Milda Simonaitis (msimonaitis@ucsd.edu, 858-822-5853).

 

 

The Diabetes Research Center held its research meeting and symposia at UCLA on February 11, 2015.

We hosted a Junior Faculty Development Workshop.

 

 

 

 

 

4th Annual Pediatric Diabetes Research Center (PDRC) Symposium

Friday, January 31, 2014 (8am - 4pm) at the Sanford Consortium for Regenerative Medicine in La Jolla.

Session topics will focus on life and death of beta-cells in diabetes with presentations from the following distinguished speakers:

· Orian Shirihai, Boston University Medical Center

· Fumihiko Urano, Washington University School of Medicine

· James D. Johnson, University of British Columbia

· Chuxia Deng, NIH/NIDDK

· Randal Kaufman, Sanford-Burnham Medical Research Institute

· Jerrold Olefsky, UC San Diego

· Ulupi Jhala, UC San Diego

· Wenxian Fu, UC San Diego

The program agenda and registration information is posted on the PDRC website at http://peds.ucsd.edu/pdrc/news-events/.

 

 

LIPID MAPS Annual Meeting 2013:
Impact of Lipidomics on Oxidized Lipids and Non-Alcoholic Fatty Liver Disease
May 7-8, 2013, La Jolla, CA
http://www.lipidmaps.org/meetings/2013annual/index.html

 

Meeting Overview

This is an exciting time for the emerging field of lipidomics. With the development and evolution of sophisticated mass spectrometers linked to highly efficient liquid chromatography systems, individual molecular species of lipids can now be isolated identified, and quantified, allowing us to begin to understand lipid metabolism and the treatment of lipid-based diseases (atherosclerosis, arthritis, cancer, diabetes, Alzheimer's disease, and other inflammatory diseases). Recent awareness that each category of lipid consists of thousands if not tens of thousands of individual molecular species requires sophisticated informatics to ensure consistent databasing and annotation of the numerous lipid molecular species and analysis of tremendous quantities of experimental data. The goal of this meeting is to bring together biological and biomedical scientists in a wide range of fields to share new findings and methods in the broader lipidomics field and to explore joint efforts to extend the use of these powerful new methods to new applications. Presentations will provide an excellent introduction for scientists new to these methods, and are sure to be of interest to lipidomics veterans who want to learn the latest techniques and research results.

This year's meeting program features two main thrusts: Oxidized lipid functioning & non-alcoholic fatty liver disease.

Several lightning talks will also be selected from poster submissions.

Poster sessions will take place on both days of the meeting. The poster abstract deadline is Saturday, March 09, 2013.

The reception and dinner Tuesday evening (included in the registration fee) are an opportunity for stimulating discussion and networking.

Please register as soon as possible, as space is limited and registration is on a first-come-first-served basis. The early registration deadline is Saturday, March 09, 2013.

We look forward to seeing you at this exciting meeting!

 

Important dates
March 09, 2013 - Early registration deadline
March 09, 2013 - Poster abstract deadline
April 05, 2013 - Hotel reservation deadline
April 23, 2013 - Registration cancellation deadline
May 7-8, 2013 - Meeting dates
May 8-9, 2013 - Committee meetings (committee members only)

 

 

 

 

2010 Diabetes Center Annual Retreat - Summary

Description: :15.jpgOn December 13th 2010 the UCSD/UCLA Diabetes Center held its Annual Retreat at the Covel Commons Conference Center at UCLA.  The event drew over seventy-five members from both campuses and affiliated institutions. After an introduction by Professor Jerry Olefsky, the DERC director, the keynote speaker, professor Peter Tontonoz of the HHMI at UCLA led the day with a lecture reviewing the control of cholesterol metabolism by nuclear receptors and the role of his newly described molecule, IDOL, which has a central role in these processes.  Dr. Pinchas Cohen, a UCLA professor and associate director of the DERC spoke about the pilot and feasibility awards and compared our center to practices around the country. Dr. Dayoung Oh, the Center’s inaugural Junior Faculty Developmental Award winner, spoke about the work described in her recent Cell paper together with Dr. Olefsky, entitled: GPR120 Is an Description: :images.jpgOmega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects. The event featured several talks from outstanding former pilot and feasibility grant awardees and the final lecture was by Professor Jake Lusis on systems genetics approach to complex cardiovascular and metabolic traits.  The event concluded with a wine and cheese reception coupled with viewing of twenty exceptional posters from young center investigators including recent feasibility grant awardees.

 

USC Southern California Research Center for ALPD and Cirrhosis JOINT SYMPOSIUM with the UCSD/UCLA DERC

 

USC Southern California Research Center for ALPD and Cirrhosis JOINT SYMPOSIUM with the UCSD/UCLA DERC

Keck School of Medicine of the University of Southern California

McKibben Hall (MCH), Room 149, Health Sciences Campus

1333 San Pablo Street, Los Angeles, CA 90033, Info: (323) 4423121 or handan@usc.edu

DECEMBER 4, 2009 at USC in Los Angeles

8:30-9:00                             Continental Breakfast

9:00-9:10                            Welcoming Remarks, Hide Tsukamoto, DVM, Ph.D.

Mechanisms of Liver Metabolism and Fatty Liver

9:10-9:35              Barry M. Forman, Ph.D., Professor and Director, Gene Regulation &         

                          Drug Discovery, The Beckman Research Inst., City of Hope Med Center

“FXR and Hepatic Metabolism: on the Fast Track”

9:40-10:05              Marc Montminy, Ph.D.

Professor, Clayton Foundation, The Salk Institute

“Regulation of Hepatic Gluconeogenesis by the TORC/CRTC

Family of CREB Coactivators”

10:10-10:35              Mark Czaja, M.D.
Professor of Medicine, Albert Einstein College of Medicine
“Regulation of Cellular Lipid Accumulation by Macroautophagy”

10:40-10:55                            Break

11:05-11:20              Kuk-Wha Lee, M.D., Ph.D.

Assistant Professor of Pediatrics, UCLA

“Contribution of the Growth Hormone/Insulin-Like Growth Factor Axis in the Pathophysiology of Hepatic Steatosis”

Pilot Projects

11:25-11:40              Ekihiro Seki, M.D., Ph.D., UCSD

“TLR Signaling in ASH vs. Non-ASH”

11:45-12:00              Kinji Asahina, Ph.D., USC

“Hepatic Stellate Cell Precursors in Developing and Fibrotic Livers”

12 :05-12:20              Jenny Yuan, Ph.D.  UCLA/West LA VA

“The Role of Protein Kinase D in Alcoholic Pancreatitis”

12:25-12:40              Bernd Schnabl, M.D., UCSD

“Early Bacterial Translocation in Alcoholic Liver Injury”

12:45-13:35                            Lunch

13:35-13:45              Special Remarks : Samir Zakhari, Ph.D. Director,

                            Division of Metabolism and Health Effects, NIAAA/NIH

13:45-14:30              Postdoc Presentations

Oxidant Stress, Inflammation, and Cancer

14:30-14:55              David Brenner, M.D.

Vice Chancellor for Health Sciences, Dean, UCSD School of Medicine

“ROS, NADPH oxidase, and liver fibrosis”

15:00-15:25               Neil Kaplowitz, M.D.

Professor and Director, USC Research Center of Liver Disease

“Mitochondrial and ER stress Coupling”

15:30-15:55              Hide Tsukamoto, DVM, PhD

Professor and Director, ALPD and Cirrhosis Research Center

“NASH Models”

16:00-16:20              Keigo Machida, Ph.D.

Assistant Professor, Dept of Mol. Microbiology and Immunology, USC

“Liver Cancer Stem Cells Generated by HCV, Alcohol, and Obesity”

16:25-16:40                            Break

16:40-17:05              Jerome Rotter, M.D.

Professor, Pediatrics and Human Genetics, UCLA/Cedars Sinai

"Genome-Wide Association of IBD -- From Susceptibility to Therapy"

17:10-17:35              Anna Gukovskaya, Ph.D.

Professor and Senior Career Scientist, UCLA, West LA VA

“Autophagy in Pancreatitis”

17:40-18:00              Simon Beaven, M.D., Instructor, Gastroenterology, UCLA

“LXR Signaling in Hepatic Inflammation and Fibrosis”  

18:05-18:15                            Closing Remarks, Jerry Olefsky, M.D.

18:30-20:30                            Reception and Dinner in the Seaver Residence Hall

 

MEETING REVIEWS for Recent DERC Meetings

Frontiers of Clinical Investigation Symposium

Clinical Investigation Institute/Nature Medicine

Bench to Bedside: Metabolism
October 8-10, 2009

REPORT: Clinical Investigation Institute/Nature Medicine Mtg

Bench to Bedside: Metabolism; October 8-10, 2009

On October 8-10, 2009, an outstanding meeting was hosted by Nature Medicine and UCSD focused on Metabolic Diseases.  The meeting was held at the Hilton Torrey Pines in La Jolla and featured a stellar group of speakers, including: Gokhan Hotamisligil, Peter Libby, Helen Hobbs, Michael Karin, Steve Shoelson, Paresh Dandona, Gerry Shulman, Ira Goldberg, Philipp Scherer, Barbara Kahn, Christopher Newgard, Tony Lam, Zofia Zukowska, Daniel Drucker, David Cummings, and Francesco Rubino.  The meeting was divided into several interrelated sessions, including:  (1) Lipids and Atherosclerosis, (2) Metabolic Disease and Inflammation, (3) Muscle Function and Metabolism, (4) Mecha­nisms of Obesity, (5) CNS Hormone Regulation, and (6) Diabetes/Metabolic Surgery.  In addition to the invited speakers, over 100 abstracts were submitted to the meeting.  Several were selected for short talks given during the program and the others were exhibited as poster presentations.  The meeting spanned a wide range of research in metabolic diseases, ranging from very basic investigation all the way up to clinical research, including the use of bariatric surgery to treat diabetes.  This range of talks revolved around the theme of the overall program, whiSANTPHH_Hilton_La_Jolla_Torrey_Pines_gallery_accom_aerial_largech was Bench to Bedside Research in Metabolism. Wolfgang Dillmann and Jerrold Olefsky from our UCSD/UCLA DERC, as well as Gary Firestein, were the organizing Committee from UCSD, partnering with Juan Carlos Lopez and Randy Levinson from Nature Medicine.

Keynote Speaker: Michael Brown
(U Texas)

The highlight of the meeting was the opening Keynote Presenta­tion by Dr. Michael Brown.  His talk covered 30 years of research from the Brown and Goldstein lab, and was a true tour de force.  The science underlying his talk was at the absolutely highest level and the presentation itself was magnificent.  He discussed their Nobel prize-winning work on the discovery of the LDL receptor, its regulation by intracellular cholesterol levels and how this led to the recognition of Familial Hypercholesterolemia.  Their findings were instrumental in the discovery and development of HMG-Co-A reductase inhibitors (“statins”), which are the most widely prescribed pharmaceuticals in the world.  Dr. Brown then went on to describe their work on the detailed mechanisms of intracellular cholesterol regulation through the coordinated interactions between SREBP, SCAP, and INSIG1.  Junior faculty and fellows attending were inspired, and many commented that this talk motivated them to fully pursue careers in biomedical science. Based on the success of this symposium, it is likely that Nature Medicine will go on to sponsor another meeting on this topic within the next two years. This meeting was immediately followed by the Western Section DERC symposium in the same hotel, which contributed to the success of our DERC meeting.

 

Speakers Included:

  • Michael Brown (U Texas)
  • Helen Hobbs (U Texas)
  • Gokhan Hotamisligil (Harvard)
  • Peter Libby (Harvard)
  • Michael Karin (UCSD)
  • Steve Shoelson (Joslin Diabetes Center)
  • Paresh Dandona (SUNY Buffalo)
  • Gerry Shulman (Yale)
  • Ira Goldberg (Columbia)
  • Phil Scherer (U Texas)
  • Barbara Kahn (Harvard)
  • Chris Newgard (Duke)
  • Tony Lam (Toronto)
  • Zofia Zukowska (Georgetown)
  • Daniel Drucker (Toronto)
  • David Cummings (U Wash)
  • Francesco Rubino (Cornell Medical Center-NYC)

Hilton La Jolla Torrey Pines
10950 North Torrey Pines Road, La Jolla, California


The First Western DERC Meeting

The First Western DERC Meeting

 

October 10th, 2009

Meeting REPORT: The First Western DERC Meeting

Oct. 10, 2009; Keynote Speaker:Professor Ron Evans, Salk Institute

In an effort to advance the scientific and mentoring collaborations among the four Western DERCs, initiated a new venue for early career investigators who received a P&F grant from their DERC in which members of the four Western DERCs (UCSD/UCLA, University of Washington, Baylor College of Medicine, and University of Colorado at Denver) interacted and presented data.  Over seventy DERC members attended the meeting, which began with a superb presentation by Dr. Ron Evans and included 10 outstanding oral presentations (two each from the five Universities), followed by a Wine & Cheese Poster session.  The general feedback from the attendees suggests that the forum was a great success and allowed enriching interactions and discussions.  We expect to hold similar meetings in collaboration with these institutions in the future.
Organizer: Dr. Pinchas Cohen.

Program

 

1:30-1:40 Opening remarks: Jerry Olefsky, Director of the DERC

 

1:40-2:20 Keynote Speaker:Professor Ron Evans, The Salk Institute

 

2:20-3:30 Introduction to the WDERC: Hassy Cohen, DERC Co-Director

 

2:30-3:45 Selected talks: Insulin Action & T2DM

Michael Downes, UCSD
       Promoter Ontology Analysis of Nuclear Receptors

Greg Morton, Univ. Washington
       Hypothalamic Signaling and Insulin Sensitivity

Laura Cobb, UCLA
       Novel Mitochondrial Peptides and their Role in Metabolism

David Maahs, Univ. Colorado, Denver
       Lipoprotein Sub-fractions and Atherogenesis in Diabetes

Andrea Hevener, UCLA
       ERα Effects on Inflammation and Insulin Action

 

3:45-4:05 Recent highlights of the UCSD/UCLA DERC Cores

Peter Tontonoz, UCLA, The Inflammation Core, Core E
       Harnessing Inflammation Markers for Diabetes Research

Gary Hardiman, UCSD, The Transcriptional Genomics Core, Core C
       New Frontiers in Sequencing

 

4:05-4:15 Tea/Coffee break

 

4:15-5:30 Selected talks on Islet Biology and T1DM

Chris Hampe, Univ. Washington
       Anti-GAD Anti-idiotypic Antibodies in T1DM

Janet Wenzlau, Univ. Colorado, Denver
       The Humoral Autoimmune Response to ZnT

Ellen Lumpkin, Baylor
       Sensory Innervation and Pancreatic Function

Vijay Yechoor, Baylor
       Auto-immunity Evading Neo-islets for Diabetes

Steven Chessler, UCSD
       Neuroligin-Neurexin Interactions in Islet Function

 

5:30-6:30 Wine & Cheese and poster-session reception on patio

 

 


Endocrine Grand Rounds